CULLEN TANIGUCHI to Prevalence
This is a "connection" page, showing publications CULLEN TANIGUCHI has written about Prevalence.
Connection Strength
0.063
-
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy. Eur J Cancer. 2023 11; 194:113357.
Score: 0.032
-
Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research. Cancer. 2023 11 01; 129(21):3430-3438.
Score: 0.031